From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery
Journal of Medical Internet Research · 2026-05-29 · 28 · e101366-e101366
DOI: 10.2196/101366 ↗At a glance
Journal article in Journal of Medical Internet Research, published online on 2026-05-29. Written by Benedette Cuffari. Major MEDLINE topics: Artificial Intelligence, Clinical Trials as Topic, Drug Discovery. Cited 1 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Pharmaceutical development is typically a long and arduous process, but advances in artificial intelligence may help streamline each stage of this pipeline. In this News and Perspectives article, JMIR Correspondent Benedette Cuffari reports on recent innovations and their potential implications for drug discovery.
Subjects
MeSH terms (MEDLINE)
Author keywords
Cite
APA
Cuffari, B. (2026). From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery. Journal of Medical Internet Research, 28, e101366-e101366. https://doi.org/10.2196/101366
Vancouver
Cuffari B. From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery. Journal of Medical Internet Research. 2026;28:e101366-e101366. doi:10.2196/101366
BibTeX
@article{Cuffari2026,
author = {Cuffari, Benedette},
title = {From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e101366--e101366},
doi = {10.2196/101366}
}
EUVIMED